Deletion of nardilysin prevents the development of steatohepatitis and liver fibrotic changes.

by Shoko Ishizu-Higashi, Hiroshi Seno, Eiichiro Nishi, Yoshihide Matsumoto, Kozo Ikuta, Motoyuki Tsuda, Yoshito Kimura, Yutaka Takada, Yuto Kimura, Yuki Nakanishi, Keitaro Kanda, Hideyuki Komekado, Tsutomu Chiba
Published 2014-01-01